Maman Biomedical

Executive Summary

Maman Biomedical is a Los Angeles-based medical device company specializing in wearable sensors and remote monitoring systems for chronic disease management. Founded in 2019, the company operates at the intersection of digital health and cardiovascular care, developing innovative products that enable continuous patient monitoring outside clinical settings. Its platform technology aims to improve outcomes for patients with conditions such as heart failure, diabetes, and hypertension by providing real-time data to clinicians and enabling early intervention. With a team of 10-50 employees, Maman Biomedical is positioned to address the growing demand for remote patient monitoring solutions, driven by an aging population and the shift toward value-based care. While the company is still in a platform stage with no disclosed funding rounds or revenues, its focus on non-invasive wearable sensors aligns with market trends favoring cost-effective, scalable solutions. The company's success will depend on regulatory clearance, clinical validation, and commercial partnerships to integrate its devices into existing healthcare workflows.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Next-Generation Wearable Monitor60% success
• Q2 2026Strategic Partnership with Major Health System40% success
• Q4 2026Series A Funding Announcement50% success